Effect of Ivacaftor on Objective and Subjective Measures of Cough in Patients with Cystic Fibrosis
{{output}}
Background and objectives: Cough is a major symptom in cystic fibrosis. Ivacaftor is a novel drug which targets the G551D mutation and has been demonstrated to improve lung function and weight in the long term. It also improves s... ...
